Patent ID: 9139642
Filing Date: 2015-09-22
Classification: A61K,A61P,C07K,C12N,G01N

Abstract:
1. A humanized monoclonal anti-Respiratory Syncytial Virus (RSV) antibody or antigen-binding fragment thereof, wherein the humanized monoclonal anti-RSV antibody or antigen binding fragment thereof comprises: a variable heavy (VH) chain containing the complementary determining region 1 (CDR1) of SEQ ID NO:405 or SEQ ID NO:437, the complementary determining region 2 (CDR2) of SEQ ID NO:406, and the complementary determining region 3 (CDR3) of SEQ ID NO:407; and a variable light (VL) chain containing the CDR1 of SEQ ID NO: 408, the CDR2 of SEQ ID NO: 409, and the CDR3 of SEQ ID NO:410.